As of January 23, 2025, Talis Biomedical (TLIS) has a market cap of $2.862 million USD. According to our data, Talis Biomedical is ranked No.9150 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 23, 2025 | $2.86 M |
-10.74%
|
Dec 31, 2024 | $3.21 M |
-76.39%
|
Dec 29, 2023 | $13.58 M |
11.36%
|
Dec 30, 2022 | $12.19 M |
-88.88%
|
Dec 31, 2021 | $0.11 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
QuidelOrtho
QDEL
|
$2.99 B |
-0.000 M
|
USA
|
Hologic
HOLX
|
$16.07 B |
-0.000 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.07 B |
1.804 B
|
USA
|
Thermo Fisher Scientific
TMO
|
$219.78 B |
-0.008 M
|
USA
|
Abbott Laboratories
ABT
|
$204.28 B |
0.006 M
|
USA
|
Becton Dickinson
BDX
|
$69.00 B |
-0.002 M
|
USA
|
Danaher
DHR
|
$176.37 B |
0.003 M
|
USA
|
Quest Diagnostics
DGX
|
$16.91 B |
-0.000 M
|
USA
|
LabCorp
LH
|
$20.28 B |
0.001 M
|
USA
|
OraSure Technologies
OSUR
|
$0.29 B |
0.000 M
|
USA
|
Market Cap | = | TLIS Stock Price | * | TLIS Shares Outstanding |
= | $1.57 | * | 1.82 M | |
= | $2.86 M |